$UTHR

AI 分析

生成于 May 11, 2026

AI Score
76/ 100
Buy$UTHR

United Therapeutics

$UTHRNASDAQHealthcareLarge-Cap

United Therapeutics develops therapies for pulmonary arterial hypertension and organ transplantation.

Market Cap
$14.0B
Revenue (TTM)
$2.8B
+12.0%
Net Income (TTM)
$1.0B
+15.0%
EPS (TTM)
$22.00
P/E Ratio
12.0
Dividend Yield
0.0%
52-Week Range
$220-$350
Beta
0.52
Dimension Scores
Fundamental
78
Technical
72
Sentiment
74
Risk / Reward
76
Momentum
70
FundTechSentRiskMome
Financial Health
Profitability
83strong
Growth
73moderate
Liquidity
84strong
Solvency
80strong
Efficiency
76strong

Valuation, technical analysis, investment thesis, risk assessment and more for $UTHR

Free · No credit card required

免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。

探索更多

用 AI 分析任意股票

获取涵盖基本面、技术面、情绪面、风险评估和投资论点的结构化研究报告——约 60 秒完成。